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A central issue in stem cell biology is to understand the mecha-
nisms that regulate the self-renewal of haematopoietic stem cells
(HSCs), which are required for haematopoiesis to persist for the
lifetime of the animal1. We found that adult and fetal mouse and
adult human HSCs express the proto-oncogene Bmi-1. The
number of HSCs in the fetal liver of Bmi-12/2 mice2 was normal.
In postnatal Bmi-12/2 mice, the number of HSCs was markedly
reduced. Transplanted fetal liver and bone marrow cells obtained
from Bmi-12/2 mice were able to contribute only transiently to
haematopoiesis. There was no detectable self-renewal of adult
HSCs, indicating a cell autonomous defect in Bmi-12/2 mice. A
gene expression analysis revealed that the expression of stem cell
associated genes3, cell survival genes, transcription factors, and
genes modulating proliferation including p16 Ink4a and p19 Arf
was altered in bone marrow cells of the Bmi-12/2 mice.
Expression of p16 Ink4a and p19 Arf in normal HSCs resulted in
proliferative arrest and p53-dependent cell death, respectively.
Our results indicate that Bmi-1 is essential for the generation of
self-renewing adult HSCs.
To understand the molecular mechanisms that control the self-
renewal of haematopoietic stem cells (HSCs), we have previously
constructed a complementary DNA library using highly purified
cells with long-term self-renewal potential4 and analysed the differ-
ential gene expression profile of HSCs5. Analysis of genes expressed
in HSCs identified Bmi-1, a member of the Polycomb Group (PcG)
family linked to malignant transformation, lymphocyte develop-
ment, neurological development and senescence of fibroblasts2,6–8.
Bmi-1 expression, which declines during haematopoietic develop-
ment9, was detected at both single-cell and ten-cell levels by
polymerase chain reaction with reverse transcription (RT–PCR)
in mouse fetal liver and adult HSCs as well as human normal and
leukaemic stem cells, indicating that HSCs express high levels of
Bmi-1 (Supplementary Fig. 1).
The Bmi-12/2 mice develop hypocellular bone marrows and die
less than 2 months after birth. To determine the function of Bmi-1 in
haematopoiesis, Bmi-12/2 mice2 in a C57Bl/Ka.Thy1.1 back-
ground1 were analysed. As reported previously2, Bmi-12/2 mice
have normal numbers of peripheral blood myeloid cells but smaller
numbers of lymphocytes, whereas the frequency of colony-forming
cells in the bone marrow was normal (Supplementary Fig. 2).
In vertebrates, haematopoiesis is organized as a hierarchy, in
which HSCs contribute to haematopoiesis for the life of the animal
and give rise to transiently reconstituting multipotent progenitors
(MPPs)1. To determine whether these mice have normal numbers of
stem cells that have lost the ability to make progeny or whether
they have a defect in the generation of stem cells, we investigated
the frequency of HSCs and MPPs from 4–5-week-old Bmi-1þ/þ,
Bmi-1þ/2 and Bmi-12/2 mice by flow cytometry (Fig. 1a, b). The
frequency of HSCs (Thy1.1lowc-kitþSca-1þLineage2 cells) in the
bone marrow of heterozygous mice was similar to that of the wild-
type littermates (about 0.01% of bone marrow cells). However, the
HSC frequency of the Bmi-12/2 mice ranged from 0% to 0.013%,
with an average of 0.005%. When the total numbers of bone marrow
cells were taken into account, Bmi-12/2 mice had an average 10-fold
(up to 45-fold) less total HSCs as measured by flow cytometry
(P ¼ 0.007; Supplementary Fig. 3). The frequency of MPP cells
(Thy1.1lowc-kitþSca-1þLineage2/low cells, which contain both
HSCs and a majority population of MPPs) in the Bmi-12/2 bone
marrow was similar to that of wild-type mice (about 0.1% of bone
marrow cells). Next, competitive repopulation experiments1 were
performed to determine the long-term reconstituting abilities
of bone marrow mononuclear cells obtained from 5-week-old
Bmi-12/2 mice. At 5 weeks after transplantation, flow cytometry
analysis of peripheral blood revealed that bone marrow cells from
both wild-type and heterozygous mice efficiently reconstituted
myeloid cells, B cells and T cells, whereas Bmi-12/2 bone marrow
cells showed a decreased capacity to reconstitute all lineages in the
transplanted animals (Fig. 1c). By 10 weeks, the mice reconstituted
with Bmi-12/2 marrow, but not with wild-type bone marrow, lost
nearly all donor-derived mature haematopoietic cells (Fig. 1d).
These results indicate that Bmi-1 might be required for self-renewal
and/or maintenance of adult HSCs.
The defect in HSCs in the bone marrow of Bmi-12/2 mice could
result from an impaired generation of self-renewing fetal and/or
adult HSCs, defective stem cell homing, or a defective bone
marrow microenvironment. We therefore next examined the
HSC compartment in fetal Bmi-12/2 mice. As measured by flow
cytometry, Bmi-12/2 mice had similar numbers of fetal liver
cells and an almost identical frequency of fetal liver HSCs10
(Thy1.1lowMac-1þSca-1þLineage2) as their wild-type littermates
(Fig. 2a). Furthermore, the fetal liver HSCs from Bmi-12/2 mice
migrated normally towards the chemokine SDF-1a, and fetal liver
cells expressed normal levels of SDF-1a and its receptor CXCR4,
important mediators of HSC homing11 (Supplementary Fig. 4).
Figure 1 Analysis of adult HSCs. a, b, Effect of Bmi-1 deletion on the frequencies of HSCs
and MPPs. The bars show the average frequencies of HSCs (a) and MPPs (b) from
eight individual mice in each group. P values (shown above the bars) were calculated
with the unpaired Student’s t-test. WT, wild type; Het., Bmi-1þ/2; KO, Bmi-12/2.
c, d, Competitive reconstitution. Donor (Ly5.1) bone marrow cells (5 £ 105) were mixed
with the same number of Ly5.2 bone marrow cells and injected into lethally irradiated
Ly5.2 mice (n ¼ 2–4). Peripheral blood was analysed 5 weeks (c) and 10 weeks (d) after
reconstitution for donor-derived myeloid, B-lymphoid and T-lymphoid cells. KO-1 and
KO-2, Bmi-1 2/2 mice 1 and 2.
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Although it is possible that Bmi-1 affects homing by other pathways,
these data suggest that the HSC defect in Bmi-12/2 bone marrow is
not likely to be the result of defective fetal liver HSC migration to the
bone marrow.
If the defects in the Bmi-12/2 mice were secondary to an
abnormal microenvironment, then fetal liver stem cells from these
mice would be able to engraft the bone marrow of wild-type mice
efficiently. If the defects were in the generation of self-renewing
HSCs, then Bmi-12/2 fetal liver HSCs would fail to permanently
engraft the bone marrow of normal adult mice. To distinguish
between these possibilities, lethally irradiated Ly5.2 congenic
mice were transplanted with 5 £ 105, 106 and 5 £ 106 Bmi-12/2
cells, or 5 £ 105 and 106 Bmi-1þ/þ embryonic day 14.5 (E14.5) fetal
liver cells. In addition, competitive reconstitution assays were
performed with 106 fetal liver cells from Bmi-1þ/þ or Bmi-12/2
mice mixed with 106 Ly5.2 bone marrow cells. At 4 weeks after
transplantation, Bmi-12/2 mice showed reconstitution of T cells
and myeloid cells, whereas B-cell reconstitution was greatly
decreased (Fig. 2b). By 8 weeks, virtually no donor-derived cells
were detected in recipient bone marrows reconstituted with
Bmi-12/2 fetal liver cells (Fig. 2c), suggesting a severe defect in
the HSCs’ ability to maintain haematopoiesis. At 8 weeks after
the original transplant, secondary bone marrow transplants were
performed with 107 donor cells. Peripheral blood analysis after 6
weeks indicated that there were no detectable Bmi-12/2 cells in the
mice with secondary transplants (Fig. 2d). Taken together with
the marked decrease in HSC numbers in the bone marrow of the
Bmi-12/2 mice, these results demonstrate that there is a profound
intrinsic defect in the maintenance of self-renewing HSCs in the
mutant mice.
To begin to understand the molecular mechanism by which
Bmi-1 affects the generation of HSCs, we compared the gene
expression profiles of bone marrow mononuclear cells obtained
from wild-type and Bmi-12/2 mice. Bmi-1 is a member of the PcG
family of transcriptional repressors that control development by the
regulation of cell growth and differentiation genes12. Microarray
analysis with bone marrow RNAs isolated from wild-type and
Bmi-12/2 mice identified several interesting genes (Fig. 3a, b and
Supplementary Table 2). These include wild-type p53-induced gene
1 (Wig1), tight-junction protein 1 (TJP1) and platelet-activating
factor acetylhydrolase isoform 1b (PAF-AHg), all of which are
expressed in embryonic, neuronal and haematopoietic stem cells3,
as well as several transcription factors, signalling proteins and
apoptosis inhibitor 6. As reported previously in embryonic fibro-
blasts, expression of p16 Ink4a and p19 Arf, which are generated by
alternative splicing from the Ink4a locus13–15, in adult bone marrow
of Bmi-12/2 mice was elevated compared with wild-type littermates
(Fig. 3a). A complete list of differentially expressed genes is given in
Supplementary Table 3. In contrast with the analysis of the adult
bone marrow, a microarray analysis of E14.5 fetal liver cells did not
show significant differences in the gene expression by the wild-type
and mutant cells (data not shown), which is consistent with the
observation that Bmi-1 is not crucial for fetal liver haematopoiesis.
Some members of the Hox family are also thought to be targets of
Bmi-1. Semiquantitative RT–PCR indicated that expression of
Hoxb4, which is important for HSC development16, was not altered
in Bmi-12/2 mice whereas Hoxa9, which functions in cell fate
decisions of haematopoietic progenitors17, was slightly upregulated
in thymus and bone marrow of Bmi-12/2 mice (Supplementary
Fig. 5).
Next, the effects of the Bmi-1 targets, p16 Ink4a and p19 Arf, on HSC
function were determined. HSCs (c-KitþSca-1þFlt32(Flk-2)
Lineage2 phenotype18) were isolated and infected with mouse
stem cell virus (MSCV) expressing green fluorescent protein
(GFP) alone or together with p16 Ink4a or p19 Arf. Two days after
infection, only 6% of cells infected with the control virus and the
p16 Ink4a virus, compared with 60% of the cells infected with the
p19 Arf virus, had lost viability as measured by exclusion of a viability
dye 7AAD (Fig. 4). When single viable GFP-positive HSCs were
placed in culture medium, 79% of the haematopoietic progenitors
infected with the control GFP virus generated more than 50 cells
after 7 days of culture (75 of 95 wells seeded). By contrast,
progenitors infected with the p16 Ink4a virus either did not prolifer-
Figure 2 Analysis of fetal liver haematopoietic stem cells in Bmi-1þ/þ, Bmi-1þ/2 and
Bmi-12/2 mice. a, The fetal liver HSC population was analysed from two Bmi-1þ/þ (WT),
three Bmi-1þ/2 (Het.) and four Bmi-12/2 (KO) fetuses by flow cytometry. P values
(shown above the bars) were calculated with the unpaired Student’s t-test.
b, c, Peripheral blood analysis of lethally irradiated mice reconstituted with 106 and
5 £ 105 Bmi-1þ/þ fetal liver cells (WT-1 and WT-0.5, respectively) and 5 £ 106, 106 and
5 £ 105 Bmi-12/2 fetal liver cells (KO-5, KO-1 and KO-0.5, respectively). WT-1 þ BM
and KO-1 þ BM indicate competitive reconstitution with 106 fetal liver cells together with
106 Ly5.2 bone marrow cells (five mice in each group). Data for 4 weeks (b) and 8 weeks
(c) after reconstitution are shown. d, Secondary bone marrow transfer. After 8 weeks of
reconstitution, 107 bone marrow cells from mice non-competitively reconstituted with 106
fetal liver cells were used to transplant lethally irradiated Ly5.2 mice. Peripheral blood
analysis was performed 6 weeks after transplant.
Figure 3 Regulation of gene expression by Bmi-1. Semiquantitative RT–PCR of genes
upregulated (a) and downregulated (b) in Bmi-12/2 (KO) mice. cDNA was reverse
transcribed from 2 mg of total RNA, and gene-specific primers were used for PCR. Aliquots
were taken at the end of the 26th, 29th, 32nd and 35th cycles. The b-actin aliquots were
taken at the end of the 17th, 20th, 23rd and 26th cycles.
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ate at all or generated only a few cells (3–10 cells, in 3 of 95 wells).
None of the p19Arf virus-infected HSCs proliferated (0 of 47 wells).
The p19Arf protein increases the level of p53 protein19. To determine
whether p19 Arf-induced cell death is mediated by p53, we infected
p532/2 HSCs (c-KitþSca-1þFlt32Lineage2 phenotype) with the
p19 Arf virus. In contrast with the wild-type HSCs, these cells were
viable 2 days after infection (Fig. 4). These results suggest that Bmi-1
targets p16 Ink4a to allow the proliferation of HSCs and p19 Arf to
inhibit apoptosis through p53.
HSCs undergo self-renewing cell divisions for the lifetime of an
animal. Once an HSC has undergone cell division, the daughter cells
must choose one of three possible fates: to remain as a stem cell, to
differentiate into progenitors or to undergo apoptosis (Fig. 5).
Although several genes have been shown to be important for stem
cell function, the mechanisms that regulate the self-renewal of HSCs
are poorly understood20–26. Our results suggest that Bmi-1 is
necessary for efficient self-renewing cell divisions of adult HSCs
but is less critical for the generation of differentiated progeny
(Fig. 5). Transplantation of Bmi-12/2 fetal liver cells resulted in
transient haematopoietic cell reconstitution. This indicates that the
transplanted mutant fetal liver HSCs might not have generated
HSCs efficiently but might have given rise to MPPs that could
sustain haematopoiesis for only 4–8 weeks. This could have been
due to the expression of other PcG genes by the MPPs. Consistent
with this model was our previous result that MPPs express more
Enx-1 than do HSCs5. Similarly, other PcG genes, such as rae28,
whose expression is necessary for fetal liver haematopoiesis to
occur27, might permit HSC proliferation in the fetus of the mutant
mice. This is consistent with the observation that the expression of
p19 Arf is elevated in adult bone marrow cells, but not in fetal liver
cells, of the mutant mice (Supplementary Fig. 5). Alternatively, the
number of self-renewing cell division of Bmi-12/2 FL-HSCs might
be restricted.
The mechanism by which Bmi-1 modulates HSC self-renewal
seems to be through the regulation of genes important for stem cell
fate decisions as well as that of survival genes, anti-proliferative
genes and stem-cell-associated genes. The gene expression data and
retroviral infection experiments implicate p16 Ink4a, p19 Arf and p53
as downstream effectors of Bmi-1 involved in the control of the
proliferation and survival of HSCs during self-renewing cell
divisions (Fig. 5). However, owing to the paucity of HSCs in the
Bmi-12/2 mice, it is not possible to determine whether the
expression levels of these genes are comparable to those of HSCs
infected with the p16Ink4a and p19 Arf retroviruses. Although the
increased expression of the p53-target gene Wig1 suggests that
p19 Arf is activated in Bmi-12/2 haematopoietic cells, the relative
contribution of each of these pathways to the regulation of self-
renewing HSC generation awaits careful analysis of the HSCs of
Bmi-12/2 mice that also harbour mutations of one or more of these
other genes. Some of the other genes identified in the microarray
analysis might also have crucial roles in stem cell biology. For
example, Wig1 and apoptosis inhibitor 6 might regulate the survival
of HSCs. As Bmi-1 has now been shown30 to be necessary for the
maintenance of mouse leukaemia and Bmi-1 is expressed by human
AML stem cells, it will be of interest to determine whether Bmi-1 has
a similar function in human leukaemia. A
Methods
Flow cytometry
Bone marrow cells were obtained by flushing the tibias and femurs of mice, and stained
with antibodies against lineage markers (CD3, CD4, CD5, CD8, Gr-1, Mac-1 and Ter119),
Sca-1, c-Kit and Thy1.1 as described1. Cells were analysed by flow cytometry with a
Vantage fluorescence-activated cell sorter (Becton Dickinson). The phenotype of adult
HSCs, multipotent progenitors (MPPs) and fetal liver HSCs are Thy1.1lowc-KitþSca-
1þLineage2, Thy1.1lowc-kitþSca-1þLineage2/low, and Thy1.1low Sca-1þMac-1þLineage2,
respectively. When Thy1.2 background mice (C57BL/6J p53-deficient mice and C57BL/6J
mice) were used, HSCs and MPPs were isolated as c-KitþSca-1þFlt32Lineage2 and
c-KitþSca-1þFlt3þLineage2 cells, respectively18.
Competitive reconstitution
Lethally irradiated C57Bl/Ka-Ly5.2 congenic mice were competitively reconstituted with
whole bone marrow or E14.5 fetal liver cells from Bmi-1þ/þ, Bmi-1þ/2 and Bmi-1 2/2
Figure 4 Effects of p16 Ink4a and p19 Arf on HSC proliferation. HSCs from wild-type and
p53 2/2 (KO) mice were infected with various MSCV viruses. After 48 h, cells were
analysed for GFP expression by flow cytometry. Percentages of GFP-positive 7AAD-
positive (dead transduced) cells are shown.
Figure 5 Proposed model for the role of Bmi-1 in HSC maintenance. a, In wild-type
mice, a HSC can undergo asymmetric cell division to generate another HSC as well as
a MPP, thereby maintaining the HSC pool. b, In the absence of Bmi-1, the increased
expression of p16 Ink4a can induce a proliferative arrest and increased expression of
p19 Arf can increase the level of p53 and its downstream target, Wig1, which, coupled
with a decreased expression of apoptosis inhibitor 6 (AI-6), results in the death of
HSCs. This results in severely impaired adult HSC self-renewal. By contrast, MPPs,
which are initially generated from the HSCs, transiently give rise to mature
haematopoietic cells.
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mice with or without the C57Bl/Ka-Ly5.2 recipient bone marrow cells1. Reconstitution of
donor (Ly5.1) myeloid and lymphoid cells was monitored by staining blood cells with
antibodies against Ly5.1, CD3, B220, Mac-1 and Gr-1. The secondary bone marrow
transplant was performed with 107 whole bone marrow cells from mice reconstituted with
Bmi-1þ/þ or Bmi-1 2/2 fetal liver cells.
Retroviral gene transfer of HSCs
Mouse stem cell viruses expressing mouse p16 Ink4a or p19 Arf cDNAs together with GFP
were produced using Phoenix ecotropic packaging cells28. Infection of HSCs was done as
described29 except that three cycles of infections were performed. After 48 h, single
GFP-positive cells were sorted into a 96-well plate containing 100 ml HSC medium29 and
grown for 7 days. Each well was scored for the presence of GFP-positive cells by
observation with a fluorescence microscope.
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Mutations in the Saccharomyces cerevisiae gene SRS2 result in the
yeast’s sensitivity to genotoxic agents, failure to recover or adapt
from DNA damage checkpoint-mediated cell cycle arrest, slow
growth, chromosome loss, and hyper-recombination1,2. Further-
more, double mutant strains, with mutations in DNA helicase
genes SRS2 and SGS1, show low viability that can be overcome by
inactivating recombination, implying that untimely recombina-
tion is the cause of growth impairment1,3,4. Here we clarify the
role of SRS2 in recombination modulation by purifying its
encoded product and examining its interactions with the Rad51
recombinase. Srs2 has a robust ATPase activity that is dependent
on single-stranded DNA (ssDNA) and binds Rad51, but the
addition of a catalytic quantity of Srs2 to Rad51-mediated
recombination reactions causes severe inhibition of these reac-
tions. We show that Srs2 acts by dislodging Rad51 from ssDNA.
Thus, the attenuation of recombination efficiency by Srs2 stems
primarily from its ability to dismantle the Rad51 presynaptic
filament efficiently. Our findings have implications for the basis
of Bloom’s and Werner’s syndromes, which are caused by
mutations in DNA helicases and are characterized by increased
frequencies of recombination and a predisposition to cancers and
accelerated ageing5.
We have been unable to overexpress Srs2 protein significantly in
yeast, suggesting that this protein is unstable in, and/or toxic to,
yeast cells. We therefore turned to Escherichia coli and an inducible
T7 promoter as vehicle for Srs2 expression. Srs2 could be revealed by
Coomassie Blue staining of E. coli extracts and by immunoblotting
with antibodies against Srs2 (Fig. 1a). We subjected E. coli lysate to
precipitation with ammonium sulphate and a five-step chromato-
graphic fractionation scheme to purify Srs2 to near-homogeneity
(Fig. 1b). Purified Srs2 has a robust ssDNA-dependent ATPase
activity (k cat $ 2,500 min
21) and a DNA helicase activity6 that is
fuelled by ATP hydrolysis (Fig. 1c).
Previous studies have unveiled an anti-recombination function in
SRS2 and a genetic interaction with RAD51 (refs 7–9). We investi-
gated whether Srs2 protein interacts physically with Rad51 protein,
and also tested its effect on the Rad51 recombinase activity10. To
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